Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Gman620on Oct 25, 2024 11:37am
195 Views
Post# 36282099

RE:New Paper by Dr. McFarland

RE:New Paper by Dr. McFarland
Summarized by Chatgpt:

Researchers created and studied five new iridium complexes that can be activated by light, focusing on their potential to treat cancer. These complexes have different structures that include thienyl units, which affect how they absorb and emit light.

They tested how well these complexes worked against various melanoma and breast cancer cell lines in both normal oxygen (normoxia) and low oxygen (hypoxia) conditions using different light colors. They found that adding more thienyl units changed how the complexes absorbed light and increased their ability to produce reactive oxygen species, which can kill cancer cells.

While these complexes were not harmful in the dark, some of them showed strong effects when activated by light, especially under normal oxygen conditions. One complex (2T-Ir) was particularly effective against certain melanoma and breast cancer cells, while another (4T-Ir) worked well under both normal and low oxygen conditions.

Overall, the findings suggest that these iridium complexes could be promising candidates for new cancer treatments that use light to activate the drugs.

<< Previous
Bullboard Posts
Next >>